mitoxantrone has been researched along with EBV Infections in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adiga, GU | 1 |
| Abebe, L | 1 |
| Wiernik, PH | 1 |
| Ancín, I | 1 |
| Sarrá, J | 1 |
| Peris, J | 1 |
| Romagosa, V | 1 |
| Domingo-Claros, A | 1 |
| Grañena, A | 1 |
1 review available for mitoxantrone and EBV Infections
| Article | Year |
|---|---|
Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bowen's Disease; Co | 2003 |
1 other study available for mitoxantrone and EBV Infections
| Article | Year |
|---|---|
Demonstration of Epstein-Barr virus in a case of multiple myeloma after renal transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epstein-Barr Virus Infections; Her | 2000 |